Background Since the publication of the British Thoracic Society (BTS) Guideline on the
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …

Acute kidney injury (AKI) is a common and serious problem affecting millions and causing
death and disability for many. In 2012, Kidney Disease: Improving Global Outcomes …

Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of
which can produce disease in humans of all ages and can affect both pulmonary and …

Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can
cause chronic pulmonary infection, particularly in individuals with pre-existing inflammatory …

Rationale: Improved therapeutic options are needed for patients with treatment-refractory
nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex …

The 2020 clinical practice guideline for the treatment of non-tuberculous mycobacterial
pulmonary disease (NTM-PD) by the American Thoracic Society, European Respiratory …

An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous
Mycobacterial Diseases | American Journal of Respiratory and Critical Care Medicine ATS …

Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than 190
species of Mycobacterium. The clinical presentation for most NTM infections is non-specific …

Rationale: Lengthy, multidrug, toxic, and low-efficacy regimens limit management of
pulmonary nontuberculous mycobacterial disease. Objectives: In this phase II study, we …

BACKGROUND There is no large study validating the appropriateness of current treatment
guidelines for Mycobacterium avium complex (MAC) lung disease. This is a retrospective …